V
Vilin Bio Med
49.40
NSE
V
Vilin Bio Med
49.40
NSE
VILINBIO Fundamentals
Company Valuation
Market Cap (₹ Cr.)
75
PE Ratio
329.30
PB Ratio
2.85
Dividend Yield
-
ROE
0.97%
ROCE
4.97%
Book Value (₹)
17.34
Face Value (₹)
10.00
Analyse VILINBIO with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Promoters | 63.89% | 63.89% | 63.89% | 63.65% | 59.57% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 34.18% | 33.49% | 33.55% | 33.95% | 30.19% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
VILINBIO Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
SME
BSE Scrip Code
0
NSE Scrip Name
VILINBIO
ISIN
INE0L4V01013



